A WW domain-containing Yes-associated protein (YAP) is a novel transcriptional co-activator

EMBO Journal

Volumn 18, Issue 9, 1999, Pages 2551-2562

  Yagi, Ryohei ^a   Chen, Lin Feng ^a   Shigesada, Katsuya ^a   Murakami, Yota ^a   Ito, Yoshiaki ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Co activator; PEBP2; PY motif; WW domain; Yes associated protein

Indexed keywords

OLIGOPEPTIDE; OSTEOCALCIN; PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; DNA BINDING; EMBRYO; GENE TARGETING; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; TRANSCRIPTION INITIATION; YEAST;

ANIMALIA;

EID: 0033522472     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/18.9.2551     Document Type: Article

References (88)

1. Andre, B. and Springael, J.Y. (1994) WWP, a new amino acid motif present in single or multiple copies in various proteins including dystrophin and the SH3-binding Yes-associated protein YAP65. Biochem. Biophys. Res. Commun., 205, 1201-1205.
2. Arias, J., Alberts, A.S., Brindle, P., Claret, F.X., Smeal, T., Karin, M., Feramisco, J. and Montminy, M. (1994) Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature, 370, 226-229.
3. Bae, S.C. et al. (1994) PEBP2αB/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials. Mol. Cell. Biol., 14, 3242-3252.
4. Bae, S.C., Takahashi, E., Zhang, Y.W., Ogawa, E., Shigesada, K., Namba, Y., Satake, M. and Ito, Y. (1995) Cloning, mapping and expression of PEBP2αC, a third gene encoding the mammalian Runt domain. Gene, 159, 245-248.
5. Baichwal, V.R. and Tjian, R. (1990) Control of c-Jun activity by interaction of a cell-specific inhibitor with regulatory domain δ: differences between v- and c-Jun. Cell, 63, 815-825.
6. Bannister, A.J. and Kouzarides, T. (1995) CBP-induced stimulation of c-Fos activity is abrogated by E1A. EMBO J., 14, 4758-4762.
7. Bannister, A.J. and Kouzarides, T. (1996) The CBP co-activator is a histone acetyltransferase. Nature, 384, 641-643.
8. Bannister, A.J., Oehler, T., Wilhelm, D., Angel, P. and Kouzarides, T. (1995) Stimulation of c-Jun activity by CBP: c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro. Oncogene, 11, 2509-2514.
9. Barlev, N.A., Candau, R., Wang, L., Darpino, P., Silverman, N. and Berger, S.L. (1995) Characterization of physical interactions of the putative transcriptional adaptor, ADA2, with acidic activation domains and TATA-binding protein. J. Biol. Chem., 270, 19337-19344.
10. Bartel, P., Chien, C.-T., Sternglanz, R. and Fields, S. (1993) Using the two-hybrid system to detect protein-protein interactions. In Hartley, D.A. (ed.), Cellular Interactions in Development: A Practical Approach. Oxford University Press, Oxford, UK, pp. 153-179.
11. Bedford, M.T., Chan, D.C. and Leder, P. (1997) FBP WW domains and the Abl SH3 domain bind to a specific class of proline-rich ligands. EMBO J., 16, 2376-2383.
12. Bork, P. and Sudol, M. (1994) The WW domain: a signalling site in dystrophin? Trends Biochem. Sci., 19, 531-533.
13. Bork, P. and Margolis, B. (1995) A phosphotyrosine interaction domain. Cell, 80, 693-694.
14. Brownell, J.E., Zhou, J., Ranalli, T., Kobayashi, R., Edmondson, D.G., Roth, S.Y. and Allis, C.D. (1996) Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell, 84, 843-851.
15. Chen, H.I. and Sudol, M. (1995) The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules, Proc. Natl Acad. Sci. USA, 92, 7819-7823.
16. Chrivia, J.C., Kwok, R.P., Lamb, N., Hagiwara, M., Montminy, M.R. and Goodman, R.H. (1993) Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature, 365, 855-859.
17. Darnell, J.E., Jr (1997) STATs and gene regulation. Science, 277, 1630-1635.
18. Ducy, P. and Karsenty, G. (1995) Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol. Cell. Biol., 15, 1858-1869.
19. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A.L. and Karsenty, G. (1997) Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell, 89, 747-754.
20. Eckner, R., Ewen, M.E., Newsome, D., Gerdes, M., DeCaprio, J.A., Lawrence, J.B. and Livingston, D.M. (1994) Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev., 8, 869-884.
21. Ermekova, K.S., Zambrano, N., Linn, H., Minopoli, G., Gertler, F., Russo, T. and Sudol, M. (1997) The WW domain of neural protein FE65 interacts with proline-rich motifs in Mena, the mammalian homolog of Drosophila enabled. J. Biol. Chem., 272, 32869-32877.
22. Ferguson, K.M., Lemmon, M.A., Sigler, P.B. and Schlessinger, J. (1995) Scratching the surface with the PH domain. Nature Struct. Biol., 2, 715-718.
23. Fujii, M., Tsuchiya, H. and Seiki, M. (1991) HTLV-1 Tax has distinct but overlapping domains for transcriptional activation and for enhancer specificity. Oncogene, 6, 2349-2352.
24. Garnier, L., Wills, J.W., Verderame, M.F. and Sudol, M. (1996) WW domains and retroviral budding. Nature, 381, 744-745.
25. Gashler, A.L., Swaminathan, S. and Sukhatme, V.P. (1993) A novel repression module, an extensive activation domain, and a bipartite nuclear localization signal defined in the immediate-early transcription factor Egr-1. Mol. Cell. Biol., 13, 4556-4571.
26. Gavva, N.R., Gavva, R., Ermekova, K., Sudol, M. and Shen, C.-K.J. (1997) Interaction of WW domains with hematopoietic transcription factor p45/NF-E2 and RNA polymerase II. J. Biol. Chem., 272, 24105-24108.
27. Gubler, U. and Hoffman, B.J. (1983) A simple and very efficient method for generating cDNA libraries. Gene, 25, 263-269.
28. Hofmann, K. and Bucher, P. (1995) The rsp5-domain is shared by proteins of diverse functions. FEBS Lett., 358, 153-157.
29. Horvai, A.E., Xu, L., Korzus, E., Brard, G., Kalafus, D., Mullen, T.-M., Rose, D.W., Rosenfeld, M.G. and Glass, C.K. (1997) Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc. Natl Acad. Sci. USA. 94, 1074-1079.
30. Ito, Y. (1996) Structural alterations in the transcription factor PEBP2/ CBF linked to four different types of leukemia. J. Cancer Res. Clin. Oncol., 122, 266-274.
31. Ito, Y. (1997) The runt protein and its companion PEBP2: a close link between this transcription factor and AML. Leukemia, 11, 279-280.
32. Ito, Y. and Bae, S.-C. (1997) The Runt domain transcription factor, PEBP2/ CBF, and its involvement in human leukemia. In Yaniv, M. and Ghsdael, J. (eds), Oncogeneses Transcriptional Regulators. Birkhauser Verlag, Basel, Switzerland, Vol. 2, pp. 107-132.
33. Janknecht, R. and Hunter, T. (1996) Transcription. A growing coactivator network. Nature, 383, 22-23.
34. Kaghad, M. et al. (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell, 90, 809-819.
35. Kagoshima, H., Akamatsu, Y., Ito, Y. and Shigesada, K. (1996) Functional dissection of the α and β subunits of transcription factor PEBP2 and the redox susceptibility of its DNA binding activity. J. Biol. Chem., 271, 33074-33082.
36. Kanda, J., Segawa, K., Ohuchi, N., Mori, S. and Ito, Y. (1994) Stimulation of polyomavirus DNA replication by wild-type p53 through the DNA-binding site. Mol. Cell. Biol., 14, 2651-2663.
37. Kanno, T., Kanno, Y., Chen, L.F., Ogawa, E., Kim, W.Y. and Ito, Y. (1998) Intrinsic transcriptional activation-inhibition domains of the polyomavirus enhancer binding protein 2/core binding factor α subunit revealed in the presence of the β subunit. Mol. Cell. Biol., 18, 2444-2454.
38. Kim, W.-Y., Sieweke, M., Ogawa, E., Wee, H.-J., Englmeier, U., Graf, T. and Ito, Y. (1999) Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains. EMBO J., 18, 1609-1620.
39. Kitabayashi, I., Yokoyama, A., Shimizu, K. and Ohki, M. (1998) Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation. EMBO J., 17, 2994-3004.
40. Komori, T. et al. (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell, 89, 755-764.
41. Kristie, T.M. and Sharp, P.A. (1990) Interactions of the Oct-1 POU subdomains with specific DNA sequences and with the HSV α-transactivator protein. Genes Dev., 4, 2383-2396.
42. Lin, Y.C. and Stavnezer, J. (1992) Regulation of transcription of the germline Igα constant region gene by an ATF element and by novel transforming growth factor-β1-responsive elements. J. Immunol., 149, 2914-2925.
43. Lin, Y.S., Ha, I., Maldonado, E., Reinberg, D. and Green, M.R. (1991) Binding of general transcription factor TFIIB to an acidic activating region. Nature, 353, 569-571.
44. Linn, H., Ermekova, K.S., Rentschler, S., Sparks, A.B., Kay, B.K. and Sudol, M. (1997) Using molecular repertoires to identify high-affinity peptide ligands of the WW domain of human and mouse YAP. Biol. Chem., 378, 531-537.
45. Lu, J., Maruyama, M., Satake, M., Bae, S.-C., Ogawa, E., Kagoshima, H., Shigesada, K. and Ito, Y. (1995) Subcellular localization of the α and β subunits of the acute myeloid leukemia-linked transcription factor PEBP2/CBF. Mol. Cell. Biol., 15, 1651-1661.
46. Marengere, L.E. and Pawson, T. (1994) Structure and function of SH2 domains. J. Cell Sci. Suppl., 18, 97-104.
47. Massagué, J. (1998) TGF-β signal transduction. Annu. Rev. Biochem., 67, 753-791.
48. Meyers, S., Downing, J.R. and Hiebert, S.W. (1993) Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions. Mol. Cell Biol., 13, 6336-6345.
49. Mizushima, S. and Nagata, S. (1990) pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res., 18, 5322.
50. Molkentin, J.D., Firulli, A.B., Black, B.L., Martin, J.F., Hustad, C.M., Copeland, N., Jenkins, N., Lyons, G. and Olson, E.N. (1996) MEF2B is a potent transactivalor expressed in early myogenic lineages. Mol. Cell Biol., 16, 3814-3824.
51. Mosser, E.A., Kasanov, J.D., Forsberg, E.C., Kay, B.K., Ney, P.A. and Bresnick, E.H. (1998) Physical and functional interactions between the transactivation domain of the hematopoietic transcription factor NF-E2 and WW domains. Biochemistry, 37, 13686-13695.
52. Mundlos, S. et al. (1997) Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell, 89, 773-779.
53. Musacchio, A., Gibson, T., Lehto, V.P. and Saraste, M. (1992) SH3 - an abundant protein domain in search of a function. FEBS Lett., 307, 55-61.
54. Nerlov, C. and Ziff, E.B. (1994) Three levels of functional interaction determine the activity of CCAAT/enhancer binding protein-α on the serum albumin promoter. Genes Dev., 8, 350-362.
55. Ogawa, E., Inuzuka, M., Maruyama, M., Satake, M., Naito-Fujimoto, M., Ito, Y. and Shigesada, K. (1993a) Molecular cloning and characterization of PEBP2β, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2α. Virology, 194, 314-331.
56. Ogawa, E., Maruyama, M., Kagoshima, H., Inuzuka, M., Lu, J., Satake, M., Shigesada, K. and Ito, Y. (1993b) PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc. Natl Acad. Sci. USA, 90, 6859-6863.
57. Ogryzko, V.V., Schiltz, R.L., Russanova, V., Howard, B.H. and Nakatani, Y. (1996) The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell, 87, 953-959.
58. Okuda, T., van-Deursen, J., Hiebert, S.W., Grosveld, G. and Downing, J.R. (1996) AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell, 84, 321-330.
59. Onate, S.A., Boonyaratanakornkit, V., Spencer, T.E., Tsai, S.Y., Tsai, M.J., Edwards, D.P. and O'Malley, B.W. (1998) The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AFI) and AF2 domains of steroid receptors. J. Biol. Chem., 273, 12101-12108.
60. Osada, M. et al. (1998) Cloning and functional analysis of human p51, which structually and functionally resembles p53. Nature Med., 4, 839-843.
61. Otto, F. et al. (1997) Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 89, 765-771.
62. Oulad-Abdelghani, M., Bouillet, P., Chazaud, C., Dolle, P. and Chambon, P. (1996) AP-2.2: a novel AP-2-related transcription factor induced by retinoic acid during differentiation of P19 embryonal carcinoma cells. Exp. Cell Res., 225, 338-347.
63. Ptashne, M. and Gann, A. (1997) Transcriptional activation by recruitment. Nature, 386, 569-577.
64. Roberts, S.G.E., Ha, I., Maldonado, E., Reinberg, D. and Green, M. (1993) Interaction between an acidic activator and transcription factor TFIIB is required for transcriptional activation. Nature, 363, 741-744.
65. Rotin, D. (1998) WW (WWP) domains: from structure to function. Curr. Top. Microbiol. Immunol., 228, 115-133.
66. Schild, L., Lu, Y., Gautschi, I., Schneeberger, E., Lifton, R.P. and Rossier, B.C. (1996) Identification of a PY motif in the epithelial Na channel subunits as a target sequence for mutations causing channel activation found in Liddle syndrome. EMBO J., 15, 2381-2387.
67. Shi, M.-J. and Stavnezer, J. (1998) CBFα3 (AML2) is induced by TGF-β1 to bind and activate the mouse germline Ig α promoter. J. Immunol., 161, 6751-6760.
68. Songyang, Z. et al. (1997) Recognition of unique carboxyl-terminal motifs by distinct PDZ domains. Science, 275, 73-77.
69. Speck, N.A. and Stacy, T. (1995) A new transcription factor family associated with human leukemias. Crit. Rev. Eukaryot. Gene Expr., 5, 337-364.
70. Staub, O. and Rotin, D. (1996) WW domains. Structure, 4, 495-499.
71. + channel deleted in Liddle's syndrome. EMBO J., 15, 2371-2380.
72. Stern, S. and Herr, W. (1991) The herpes simplex virus trans-activator VP16 recognizes the Oct-1 homeo domain: evidence for a homeo domain recognition subdomain. Genes Dev., 5, 2555-2566.
73. Stringer, K.F., Ingles, C.J. and Greenblatt, J. (1990) Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID. Nature, 345, 783-786.
74. Sudol, M. (1994) Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product. Oncogene, 9, 2145-2152.
75. Sudol, M., Bork, P., Einbond, A., Kastury, K., Druck, T., Negrini, M., Huebner, K. and Lehman, D. (1995) Characterization of the mammalian YAP (Yes-associated protein) gene and its role in defining a novel protein module, the WW domain. J. Biol. Chem., 270, 14733-14741.
76. Tanaka, T. et al. (1996) The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability. Mol. Cell. Biol., 16, 3967-3979.
77. Tjian, R. and Maniatis, T. (1994) Transcriptional activation: a complex puzzle with few easy pieces. Cell, 77, 5-8.
78. Torchia, J., Glass, C. and Rosenfeld, M.G. (1998) Co-activators and co-repressors in the integration of transcriptional responses. Curr. Opin. Cell Biol., 10, 373-383.
79. Vesque, C. and Charnay, P. (1992) Mapping functional regions of the segment-specific transcription factor Krox-20. Nucleic Acids Res., 20, 2485-2492.
80. Wade, P.A. and Wollfe, A.P. (1997) Histone acetyltransferases in control. Curr. Biol., 7, 82-84.
81. Wang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A.H. and Speck, N.A. (1996) Disruption of the cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl Acad. Sci. USA, 93, 3444-3449.
82. Williams, T. and Tjian, R. (1991) Analysis of the DNA-binding and activation properties of the human transcription factor AP-2. Genes Dev., 5, 670-682.
83. Willy, P.J., Umesono, K., Ong, E.S., Evans, R.M., Heyman, R.A. and Mangelsdorf, D.J. (1995) LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev., 9, 1033-1045.
84. Yang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M.D., Dotsch, V., Andrews, N.C., Caput, D. and McKeon, F. (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell, 2, 305-316.
85. Yang, X.J., Ogryzko, V.V., Nishikawa, J., Howard, B.H. and Nakatani, Y. (1996) A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature, 382, 319-324.
86. Zhang, Y.W., Bae, S.-C., Takahashi, E. and Ito, Y. (1997a) The cDNA cloning of the transcripts of human PEBP2αA/CBFA1 mapped to 6p12.3-p12.1, the locus for cleidocranial dysplasia. Oncogene, 15, 367-371.
87. Zhang, Y.W., Bae, S.C., Huang, G., Fu, Y.X., Lu, J., Ahn, M.Y., Kanno, Y., Kanno, T. and Ito, Y. (1997b) A novel transcript encoding an N-terminally truncated AML1/PEBP2αB protein interferes with transactivation and blocks granulocytic differentiation of 32Dcl3 myeloid cells. Mol. Cell. Biol., 17, 4133-4145.
88. Zhu, X., Yeadon, J.E. and Burden, S.J. (1994) AML1 is expressed in skeletal muscle and is regulated by innervation. Mol. Cell. Biol., 14, 8051-8057.